52 related articles for article (PubMed ID: 38755600)
1. Ultra-small Janus nanoparticle-induced activation of ferroptosis for synergistic tumor immunotherapy.
Wang J; Wang Z; Li L; Wang M; Chang J; Gao M; Wang D; Li C
Acta Biomater; 2024 Jun; 181():362-374. PubMed ID: 38663684
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potentials of FexMoyS-PEG nanoparticles in colorectal cancer: a multimodal approach via ROS-ferroptosis-glycolysis regulation.
Yu Z; Wang C; Ye Y; Wang S; Jiang K
J Nanobiotechnology; 2024 May; 22(1):253. PubMed ID: 38755600
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-Responsive Nanoradiosensitizers for Enhanced Cancer Radiotherapy.
Xiao W; Zhao L; Sun Y; Yang X; Fu Q
Small Methods; 2024 Jan; 8(1):e2301131. PubMed ID: 37906050
[TBL] [Abstract][Full Text] [Related]
4. Combination cancer imaging and phototherapy mediated by membrane-wrapped nanoparticles.
Aboeleneen SB; Scully MA; Kramarenko GC; Day ES
Int J Hyperthermia; 2023; 40(1):2272066. PubMed ID: 37903544
[TBL] [Abstract][Full Text] [Related]
5. CHAC2 promotes lung adenocarcinoma by regulating ROS-mediated MAPK pathway activation.
Peng W; Wen L; Jiang R; Deng J; Chen M
J Cancer; 2023; 14(8):1309-1320. PubMed ID: 37283797
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment signaling and therapeutics in cancer progression.
Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
[TBL] [Abstract][Full Text] [Related]
7. Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?
Olguin JE; Mendoza-Rodriguez MG; Sanchez-Barrera CA; Terrazas LI
World J Gastrointest Oncol; 2023 Feb; 15(2):251-267. PubMed ID: 36908325
[TBL] [Abstract][Full Text] [Related]
8. Modulating Glycolysis to Improve Cancer Therapy.
Chelakkot C; Chelakkot VS; Shin Y; Song K
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768924
[TBL] [Abstract][Full Text] [Related]
9. New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy.
Freitas SC; Sanderson D; Caspani S; Magalhães R; Cortés-Llanos B; Granja A; Reis S; Belo JH; Azevedo J; Gómez-Gaviro MV; Sousa CT
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672333
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional ROS-Responsive and TME-Modulated Lipid-Polymer Hybrid Nanoparticles for Enhanced Tumor Penetration.
Ni R; Huang L; Li Z; Zhang W; Wang Y; Shen Y; Wang J; Lu W
Int J Nanomedicine; 2022; 17():5883-5897. PubMed ID: 36478745
[TBL] [Abstract][Full Text] [Related]
11. Managing the TME to improve the efficacy of cancer therapy.
Bilotta MT; Antignani A; Fitzgerald DJ
Front Immunol; 2022; 13():954992. PubMed ID: 36341428
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment: barrier or opportunity towards effective cancer therapy.
Tiwari A; Trivedi R; Lin SY
J Biomed Sci; 2022 Oct; 29(1):83. PubMed ID: 36253762
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermia increases HSP production in human PDMCs by stimulating ROS formation, p38 MAPK and Akt signaling, and increasing HSF1 activity.
Liu JF; Chen PC; Ling TY; Hou CH
Stem Cell Res Ther; 2022 Jun; 13(1):236. PubMed ID: 35659731
[TBL] [Abstract][Full Text] [Related]
14. c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses.
Wang XY; Wei Y; Hu B; Liao Y; Wang X; Wan WH; Huang CX; Mahabati M; Liu ZY; Qu JR; Chen XD; Chen DP; Kuang DM; Wang XH; Chen Y
Signal Transduct Target Ther; 2022 Apr; 7(1):105. PubMed ID: 35430810
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathways associated with oxidative stress and their potential applications in radiotherapy (Review).
Liu R; Bian Y; Liu L; Liu L; Liu X; Ma S
Int J Mol Med; 2022 May; 49(5):. PubMed ID: 35293589
[TBL] [Abstract][Full Text] [Related]
16. The role of ROS in tumour development and progression.
Cheung EC; Vousden KH
Nat Rev Cancer; 2022 May; 22(5):280-297. PubMed ID: 35102280
[TBL] [Abstract][Full Text] [Related]
17. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
18. A Facile Strategy of Boosting Photothermal Conversion Efficiency through State Transformation for Cancer Therapy.
Li J; Wang J; Zhang J; Han T; Hu X; Lee MMS; Wang D; Tang BZ
Adv Mater; 2021 Dec; 33(51):e2105999. PubMed ID: 34651361
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
